Israel - hebraisk - Ministry of Health

teva medical marketing ltd. - coagulation factor viii recombinant 250 iu/vial - powder for solution for injection - coagulation factor viii - the use of recombinate is indicated in the treatment and prophylaxis of bleeding in patients with haemophilia a (congenital factor viii deficiency).recombinate is also indicated in the perioperative management of patients with haemophilia a. recombinate is appropriate for use in children of all ages including the newborn. (safety and efficacy studies have been performed in both previously treated and previously untreated children). the product in not suitable for the treatment of von willebrand's disease.

Israel - hebraisk - Ministry of Health

teva medical marketing ltd. - coagulation factor viii recombinant 1000 iu/vial - powder for solution for injection - coagulation factor viii - the use of recombinate is indicated in the treatment and prophylaxis of bleeding in patients with haemophilia a (congenital factor viii deficiency). recombinate is also indicated in the perioperative management of patients with haemophilia a. recombinate is appropriate for use in children of all ages including the newborn. (safety and efficacy studies have been performed in both previously treated and previously untreated children). the product in not suitable for the treatment of von willebrand's disease.

Israel - hebraisk - Ministry of Health

teva medical marketing ltd. - factor viii human coagulation 250 iu/vial - powder for solution for injection - coagulation factor viii - treatment and prophylaxis of bleeding in patients with congenital (haemophilia a) or acquired factor viii deficiency. von willebrand's disease with factor viii deficiency.

Israel - hebraisk - Ministry of Health

teva medical marketing ltd. - factor viii human coagulation vhsd treated 500 iu/vial - powder for solution for injection - coagulation factor viii - treatment and prophylaxis of bleeding in patients with congenital (haemophilia a) or acquired factor viii deficiency. von willebrand's disease with factor viii deficiency.

Israel - hebraisk - Ministry of Health

teva medical marketing ltd. - factor viii human coagulation 1000 iu/vial - powder for solution for injection - coagulation factor viii - treatment and prophylaxis of bleeding in patients with congenital (haemophilia a) or acquired factor viii deficiency. von willebrand's disease with factor viii deficiency.

Israel - hebraisk - Ministry of Health

teva medical marketing ltd. - coagulation factor viii recombinant 500 iu/vial - powder for solution for injection - coagulation factor vii - the use of recombinate is indicated in the treatment and prophylaxis of bleeding in patients with haemophilia a (congenital factor viii deficiency). recombinate is also indicated in the perioperative management of patients with haemophilia a. recombinate is appropriate for use in children of all ages including the newborn. (safety and efficacy studies have been performed in both previously treated and previously untreated children). the product in not suitable for the treatment of von willebrand's disease.

Israel - hebraisk - Ministry of Health

csl behring ltd., israel - factor xiii - powder for solution for injection - factor xiii 200 - 320 iu - coagulation factor xiii - coagulation factor xiii - congenital or acquired factor xiii deficiency, or to promote healing of wounds and bone fractures. congenital deficiency of factor xiii and resultant haemorrhagic syndroms

Israel - hebraisk - Ministry of Health

csl behring ltd., israel - factor xiii - powder for solution for injection - factor xiii 1250 iu - coagulation factor xiii - coagulation factor xiii - congenital or acquired factor xiii deficiency or to promote healing of wounds and bone fractures. congenital deficiency of factor xiii and resultant haemorrhagic syndroms

Israel - hebraisk - Ministry of Health

rafa laboratories ltd - citric acid anhydrous 1000 mg; sodium bicarbonate 1200.6 mg - powder - combinations - to alkalinize the urine to relieve symptoms of cystitis.

Israel - hebraisk - Ministry of Health

reckitt benckiser (near east) ltd - tolnaftate 1 %w/w - powder - tolnaftate - for topical foot fungi.